Updated CKD Guidelines Promote Cystatin C, Risk Equations, and SGLT2 Inhibitors

[ad_1]

(MedPage Today) — Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization’s updated clinical practice guideline.
In a synopsis of the recently published guideline — serving…

[ad_2]

Source link : https://www.medpagetoday.com/nephrology/generalnephrology/114580

Author :

Publish date : 2025-03-10 21:00:00

Copyright for syndicated content belongs to the linked Source.